Literature DB >> 82099

Further experience in the treatment of severe attacks of ulcerative colitis.

S C Truelove, C P Willoughby, E G Lee, M G Kettlewell.   

Abstract

One hundred courses of an intensive intravenous regimen have been used in 87 patients with severe attacks of ulcerative colitis during the past 5 years, 11 of the patients having been treated more than once during separate admissions to hospital. 60% of the attacks responded swiftly to the regimen, and the patients were symptom-free at the end of the 5-day course. In 15% there was improvement but the patients were not entirely symptom-free. In 25% failure to respond resulted in emergency colectomy, the usual operation being proctocolectomy as a single-stage procedure. There were no deaths directly due to ulcerative colitis or to surgical treatment in these patients during the period of the study, the mean period of follow-up being 25 months; but 4 elderly patients died from unrelated causes. These favourable results are better than most published figures. The advantages of the intensive medical regimen are that: (i) many patients quickly go into clinical remission, which is frequently sustained; and (ii) failure to improve can be regarded as a clear-cut indication for emergency surgery.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82099     DOI: 10.1016/s0140-6736(78)91816-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  47 in total

1.  Prediction of short-term outcome for patients with active ulcerative colitis.

Authors:  N Oshitani; T Matsumoto; Y Jinno; Y Sawa; J Hara; S Nakamura; T Arakawa; A Kitano; T Kuroki
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

2.  New steroids for IBD: progress report.

Authors:  S B Hanauer
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

3.  Cytapheresis in patients with severe ulcerative colitis after failure of intravenous corticosteroid: a long-term retrospective cohort study.

Authors:  Ken Fukunaga; Kazuko Nagase; Takeshi Kusaka; Nobuyuki Hida; Yoshio Ohda; Koji Yoshida; Katsuyuki Tozawa; Koji Kamikozuru; M Iimuro; Shiro Nakamura; Hiroto Miwa; Takayuki Matsumoto
Journal:  Gut Liver       Date:  2009-03-31       Impact factor: 4.519

Review 4.  Drug management of ulcerative colitis.

Authors:  M A Kamm; A Senapati
Journal:  BMJ       Date:  1992-07-04

Review 5.  Role of nutrition in inflammatory bowel disease: an overview.

Authors:  M L Clark
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

Review 6.  New pathophysiological insights and modern treatment of IBD.

Authors:  Matthias A Engel; Markus F Neurath
Journal:  J Gastroenterol       Date:  2010-03-09       Impact factor: 7.527

7.  Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses.

Authors:  F Carbonnel; A Boruchowicz; B Duclos; J C Soulé; E Lerebours; M Lémann; J Belaïche; J F Colombel; J Cosnes; J P Gendre
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 8.  [What is the role of nutrition in ulcerative colitis? A contribution to the current status of diet therapy in treatment of inflammatory bowel diseases].

Authors:  M Bartels; E Nagel; R Pichlmayr
Journal:  Langenbecks Arch Chir       Date:  1995

Review 9.  Treatment of severe steroid refractory ulcerative colitis.

Authors:  Gert Van Assche; Séverine Vermeire; Paul Rutgeerts
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

Review 10.  Severe ulcerative colitis: at what point should we define resistance to steroids?

Authors:  Maria Esteve; Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.